Danaher Corp (DHR)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account
Sell

$183.19

Buy

$193.74

arrow-down$-0.10 (-0.05%)

Danaher Corp designs, manufactures and markets professional, medical, industrial and commercial products and services. It markets its products under the brand of Beckman Coulter, Aperio, Dexis, Chemtreat and others.
Prices updated at 30 May 2025, 09:08 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Steven M. Rales
CEO
Mr. Rainer M. Blair
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
63,000
Head office
2200 Pennsylvania Avenue, North West
Washington
United States
20037-1701
mobile
+1 202 828-0850
letter
investor.relations@danaher.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Charles W. Lamanna
Independent Director
-----
Mr. Alan G. Spoon, J.D.
Independent Director
---0.35m-
Ms. Linda Hefner Filler
Lead Independent Director
0.19m--0.39m-
Mr. John T. Schwieters
Independent Director
0.15m--0.36m-
Mr. Mitchell P. Rales
Director
-----
Mr. Steven M. Rales
Chairman of the Board
-----
Mr. Daniel A. Raskas
Senior Vice President, Corporate Development
-----
Dr. Elias A. Zerhouni, M.D.
Independent Director
---0.35m-
Ms. Teri L. List-Stoll
Independent Director
0.13m--0.33m-
Mr. R. Bradley Gray
Senior Vice President, Strategic Development
-----
Mr. Matthew R. McGrew
Executive Vice President and Chief Financial Officer
0.99m--7.47m-
Mr. Rainer M. Blair
Director, President and Chief Executive Officer
1.35m--22.11m-
Mr. Brian W. Ellis
Senior Vice President and General Counsel
0.80m--4.96m-
Dr. Jose-Carlos Gutierrez-Ramos, PhD
Senior Vice President and Chief Scientific Officer
0.86m--7.50m-
Mr. Feroz Dewan
Independent Director
---0.33m-
Professor Raymond C. Stevens, PhD
Independent Director
---0.33m-
Dr. Jessica L. Mega, M.D.,M.P.H.
Independent Director
0.13m--0.33m-
Mr. A. Shane Sanders
Independent Director
---0.33m-
Mr. Christopher M. Bouda
Vice President and Chief Accounting Officer
-----
Ms. Georgeann F. Couchara
Senior Vice President, Human Resources
0.73m--5.34m-
Mr. Christopher Paul Riley
Executive Vice President
-----
Ms. Julie A. Sawyer Montgomery
Executive Vice President
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc59,981,0880.222312309660.38655330 Apr 20258.38
BlackRock Inc52,602,1940.2264923918174.76359130 Apr 20257.35
State Street Corp27,463,9710.23236797880.29136530 Apr 20253.84
Vanguard Investments Australia Ltd20,932,4522.25227-517071-30 Apr 20252.92
Vanguard Total Stock Market Index Fund20,634,9980.239363172271.56132830 Apr 20252.88

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
25 Nov 2024-Mr. Daniel A. Raskas238.001,992,06015,225--
26 Nov 2024-Mr. Daniel A. Raskas-----
26 Nov 2024-Mr. Daniel A. Raskas236.596,226,49715,225--
26 Nov 2024-Mr. Daniel A. Raskas58.591,541,97241,543--
21 Nov 2024-Mr. Mitchell P. Rales--1,590,228--
21 Nov 2024-Mr. Matthew R. McGrew235.05309,82910,148--
21 Nov 2024-Mr. Christopher M. Bouda235.0517,629621--
15 Nov 2024-Ms. Julie A. Sawyer Montgomery230.5061,0835,502--
25 Oct 2024-Mr. Alan G. Spoon, J.D.245.3944,66129,552--
25 Oct 2024-Ms. Linda Hefner Filler245.392,2098,851--
25 Oct 2024-Dr. Elias A. Zerhouni, M.D.245.3941,47117,188--
25 Oct 2024-Ms. Teri L. List-Stoll245.391,9637,587--
25 Oct 2024-Mr. Feroz Dewan245.3931,4101,237--
25 Oct 2024-Professor Raymond C. Stevens, PhD245.3932,8826,236--
25 Oct 2024-Dr. Pardis C. Sabeti, M.D.245.3931,9012,805--
25 Oct 2024-Mr. A Shane Sanders245.3931,6551,810--
26 Aug 2024-Ms. Georgeann F. Couchara268.37255,4834,212--
01 Aug 2024-Ms. Linda Hefner Filler59.34233,08845,077--
01 Aug 2024-Ms. Linda Hefner Filler-----
01 Aug 2024-Ms. Linda Hefner Filler279.501,097,87641,149--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.